These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22350222)

  • 21. Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency.
    la Marca G; Canessa C; Giocaliere E; Romano F; Duse M; Malvagia S; Lippi F; Funghini S; Bianchi L; Della Bona ML; Valleriani C; Ombrone D; Moriondo M; Villanelli F; Speckmann C; Adams S; Gaspar BH; Hershfield M; Santisteban I; Fairbanks L; Ragusa G; Resti M; de Martino M; Guerrini R; Azzari C
    J Allergy Clin Immunol; 2013 Jun; 131(6):1604-10. PubMed ID: 23280131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy for ADA-SCID: defining the factors for successful outcome.
    Gaspar HB
    Blood; 2012 Nov; 120(18):3628-9. PubMed ID: 23118212
    [No Abstract]   [Full Text] [Related]  

  • 23. Updated Management Guidelines for Adenosine Deaminase Deficiency.
    Grunebaum E; Booth C; Cuvelier GDE; Loves R; Aiuti A; Kohn DB
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1665-1675. PubMed ID: 36736952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.
    Cicalese MP; Ferrua F; Castagnaro L; Pajno R; Barzaghi F; Giannelli S; Dionisio F; Brigida I; Bonopane M; Casiraghi M; Tabucchi A; Carlucci F; Grunebaum E; Adeli M; Bredius RG; Puck JM; Stepensky P; Tezcan I; Rolfe K; De Boever E; Reinhardt RR; Appleby J; Ciceri F; Roncarolo MG; Aiuti A
    Blood; 2016 Jul; 128(1):45-54. PubMed ID: 27129325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.
    Tartibi HM; Hershfield MS; Bahna SL
    Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26684479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.
    Kohn DB; Booth C; Shaw KL; Xu-Bayford J; Garabedian E; Trevisan V; Carbonaro-Sarracino DA; Soni K; Terrazas D; Snell K; Ikeda A; Leon-Rico D; Moore TB; Buckland KF; Shah AJ; Gilmour KC; De Oliveira S; Rivat C; Crooks GM; Izotova N; Tse J; Adams S; Shupien S; Ricketts H; Davila A; Uzowuru C; Icreverzi A; Barman P; Campo Fernandez B; Hollis RP; Coronel M; Yu A; Chun KM; Casas CE; Zhang R; Arduini S; Lynn F; Kudari M; Spezzi A; Zahn M; Heimke R; Labik I; Parrott R; Buckley RH; Reeves L; Cornetta K; Sokolic R; Hershfield M; Schmidt M; Candotti F; Malech HL; Thrasher AJ; Gaspar HB
    N Engl J Med; 2021 May; 384(21):2002-2013. PubMed ID: 33974366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adenosine deaminase 1 deficiency, an inborn error of metabolism underlying a severe form of combined immunodeficiency].
    Giraud A; Lavocat MP; Cremillieux C; Patural H; Thouvenin S; David A; Perignon JL; Stephan JL
    Arch Pediatr; 2015 Jun; 22(6):630-5. PubMed ID: 25842197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry.
    Kuo CY; Garabedian E; Puck J; Cowan MJ; Sullivan KE; Buckley RH; Cunningham-Rundles C; Marsh R; Candotti F; Kohn DB
    J Clin Immunol; 2020 Nov; 40(8):1124-1131. PubMed ID: 32880085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal T-cell engraftment impedes with diagnosis of a SCID-ADA patient.
    Lanfranchi A; Lougaris V; Notarangelo LD; Soncini E; Comini M; Beghin A; Bolda F; Montanelli A; Imberti L; Porta F
    Clin Immunol; 2018 Aug; 193():118-120. PubMed ID: 29355610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy.
    Moretti FA; Giardino G; Attenborough TCH; Gkazi AS; Margetts BK; la Marca G; Fairbanks L; Crompton T; Gaspar HB
    Sci Rep; 2021 Dec; 11(1):23221. PubMed ID: 34853379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.
    Shaw KL; Garabedian E; Mishra S; Barman P; Davila A; Carbonaro D; Shupien S; Silvin C; Geiger S; Nowicki B; Smogorzewska EM; Brown B; Wang X; de Oliveira S; Choi Y; Ikeda A; Terrazas D; Fu PY; Yu A; Fernandez BC; Cooper AR; Engel B; Podsakoff G; Balamurugan A; Anderson S; Muul L; Jagadeesh GJ; Kapoor N; Tse J; Moore TB; Purdy K; Rishi R; Mohan K; Skoda-Smith S; Buchbinder D; Abraham RS; Scharenberg A; Yang OO; Cornetta K; Gjertson D; Hershfield M; Sokolic R; Candotti F; Kohn DB
    J Clin Invest; 2017 May; 127(5):1689-1699. PubMed ID: 28346229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.
    Migliavacca M; Assanelli A; Ponzoni M; Pajno R; Barzaghi F; Giglio F; Ferrua F; Frittoli M; Brigida I; Dionisio F; Nicoletti R; Casiraghi M; Roncarolo MG; Doglioni C; Peccatori J; Ciceri F; Cicalese MP; Aiuti A
    Front Immunol; 2018; 9():113. PubMed ID: 29456531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical Hemolytic Uremic Syndrome (aHUS) and Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)-Two Diseases That Exacerbate Each Other: Case Report.
    Bogdał A; Badeński A; Pac M; Wójcicka A; Badeńska M; Didyk A; Trembecka-Dubel E; Dąbrowska-Leonik N; Walaszczyk M; Matysiak N; Morawiec-Knysak A; Szczepański T; Szczepańska M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe combined immune deficiency in an adenosine deaminase-deficient patient.
    Ozdemir O
    Allergy Asthma Proc; 2006; 27(2):172-4. PubMed ID: 16724639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety.
    Cicalese MP; Ferrua F; Castagnaro L; Rolfe K; De Boever E; Reinhardt RR; Appleby J; Roncarolo MG; Aiuti A
    Mol Ther; 2018 Mar; 26(3):917-931. PubMed ID: 29433935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.
    Hassan A; Booth C; Brightwell A; Allwood Z; Veys P; Rao K; Hönig M; Friedrich W; Gennery A; Slatter M; Bredius R; Finocchi A; Cancrini C; Aiuti A; Porta F; Lanfranchi A; Ridella M; Steward C; Filipovich A; Marsh R; Bordon V; Al-Muhsen S; Al-Mousa H; Alsum Z; Al-Dhekri H; Al Ghonaium A; Speckmann C; Fischer A; Mahlaoui N; Nichols KE; Grunebaum E; Al Zahrani D; Roifman CM; Boelens J; Davies EG; Cavazzana-Calvo M; Notarangelo L; Gaspar HB;
    Blood; 2012 Oct; 120(17):3615-24; quiz 3626. PubMed ID: 22791287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National experience with adenosine deaminase deficiency related SCID in Polish children.
    Dąbrowska-Leonik N; Piątosa B; Słomińska E; Bohynikova N; Bernat-Sitarz K; Bernatowska E; Wolska-Kuśnierz B; Kałwak K; Kołtan S; Dąbrowska A; Goździk J; Ussowicz M; Pac M
    Front Immunol; 2022; 13():1058623. PubMed ID: 36685585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.
    Sokolic R; Maric I; Kesserwan C; Garabedian E; Hanson IC; Dodds M; Buckley R; Issekutz AC; Kamani N; Shaw K; Tan B; Bali P; Hershfield MS; Kohn DB; Wayne AS; Candotti F
    Blood; 2011 Sep; 118(10):2688-94. PubMed ID: 21725047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chondroosseous dysplasia in severe combined immunodeficiency due to adenosine deaminase deficiency (chondroosseous dysplasia in ADA deficiency SCID).
    Chakravarti VS; Borns P; Lobell J; Douglas SD
    Pediatr Radiol; 1991; 21(6):447-8. PubMed ID: 1749685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow transplantation and alternatives for adenosine deaminase deficiency.
    Gaspar HB
    Immunol Allergy Clin North Am; 2010 May; 30(2):221-36. PubMed ID: 20493398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.